Results 221 to 230 of about 105,804 (267)
Some of the next articles are maybe not open access.

Nonfunctioning Pituitary Tumors and Pituitary Incidentalomas

Endocrinology and Metabolism Clinics of North America, 2008
Clinically nonfunctioning adenomas (CNFAs) range from being completely asymptomatic, and therefore detected at autopsy or as incidental findings on head MRI or CT scans performed for other reasons, to causing significant hypothalamic/pituitary dysfunction and visual field compromise because of their large size.
openaire   +2 more sources

Scintigraphy of Pituitary Tumors

2000
Several neoplastic and non-neoplastic lesions may arise within the sellar and parasellar regions (Table 1). Among these, pituitary adenomas are the most common. Almost all pituitary tumors are benign, although they may display signs of local invasion or show histological evidence of malignancy.
de Herder, W.W.   +3 more
openaire   +2 more sources

Pituitary tumor apoplexy

Journal of Clinical Neuroscience, 2015
We review the etiology, investigations, management and outcomes of pituitary tumor apoplexy. Pituitary tumor apoplexy is a clinical syndrome which typically includes the acute onset of headache and/or visual disturbance, cranial nerve palsy and partial or complete endocrine dysfunction.
Philip C, Johnston   +3 more
openaire   +2 more sources

Pathology of Pituitary Tumors

Endocrinology and Metabolism Clinics of North America, 1987
This article reviewed the classification, morphologic features, and pathogenesis of human hypophyseal adenomas and differences between hyperplasia and adenoma. Histologic, immunohistochemical, and electron microscopic investigation obtained a deeper insight into several aspects of pituitary cytopathology.
K, Kovacs, E, Horvath
openaire   +2 more sources

Pituitary tumors and pregnancy

American Journal of Obstetrics and Gynecology, 1978
This paper contains a review of the natural history of pituitary tumors in nonpregnant and pregnant patients. Data were drawn from previously published reports and from responses to a questionnaire and were analyzed by life-table techniques. Follow-up of 62 nonpregnant patients with untreated pituitary tumors with and without visual field changes ...
D M, Magyar, J R, Marshall
openaire   +2 more sources

Pituitary tumors

Anti-Cancer Drugs, 1992
This article reviews the current general approach to the biochemical diagnosis and the treatment of pituitary tumors with special reference to medical treatment with dopamine agonists and somatostatin analogs. Dopamine agonists are the treatment of choice in patients with prolactin producing tumors.
openaire   +2 more sources

Targeting Pituitary Tumors

Hormone Research in Paediatrics, 2007
<i>Background:</i> Pituitary tumors are common and usually grow insidiously over many years. Rarely fatal, treatment still requires multiple cytoreductive surgeries and/or radiation therapy with its attendant side effects. As a disease process of regulatory pathways, pituitary tumors offer numerous potential therapeutic targets, and many ...
openaire   +2 more sources

Management of Pituitary Tumors

Neurologic Clinics, 1986
Pituitary adenomas represent the only true adenomas of the cranial cavity. In 1000 asymptomatic pituitary glands examined at autopsy, there was a 22.4 per cent incidence of undetected microadenomas. Advances in diagnostic endocrinology, in radiologic imaging, and in surgical and medical treatments have brought many more patients to the attention of the
K D, Post, K, Muraszko
openaire   +2 more sources

THE PATHOLOGY OF PITUITARY TUMORS

Endocrinology and Metabolism Clinics of North America, 1999
The pathologist plays an important role in the distinction of pituitary adenomas from other tumors and tumor-like lesions of the sellar region, and in the accurate morphologic characterization of pitutiary adenomas. A clinicopathologic classification of pituitary adenomas is based on cell differentiation correlated with clinical evidence of hormone ...
openaire   +2 more sources

Pituitary Gland Tumors

2005
Few human pituitary tumor cell lines have been established. This scarcity may be related to the fact that hormone production rapidly declines within weeks to months after initiation of the culture. In addition, the number of proliferating cells in pituitary adenomas is very low.
Hofland, Leo, Lamberts, S.W.J.
openaire   +2 more sources

Home - About - Disclaimer - Privacy